The dual role of nitric oxide in glioma

Wiaam Badn1, Peter Siesjö

  • 1Department of Neurosurgery, Lund University Hospital, Lund, Sweden.

Insights

Malignant gliomas have a poor prognosis, driving research into new treatments. Modulating nitric oxide (NO) shows promise for anti-glioma effects, influencing tumor growth, vascularity, and treatment response.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant gliomas remain a significant challenge with poor patient outcomes.
  • Nitric oxide (NO) plays a complex, dual role in glioma biology.
  • Understanding NO's multifaceted effects is crucial for developing novel therapies.

Purpose of the Study:

  • To explore the potential of modulating nitric oxide (NO) for anti-glioma strategies.
  • To elucidate the diverse mechanisms by which NO impacts glioma progression.
  • To identify therapeutic opportunities through NO pathway manipulation.

Main Methods:

  • Review of existing literature on nitric oxide (NO) in glioma.
  • Analysis of NO's influence on glioma cell proliferation, invasion, and vascular function.
  • Investigation of NO's role in chemo/radiotherapy and immune responses against gliomas.

Main Results:

  • Nitric oxide (NO) exhibits dual effects, promoting or inhibiting glioma growth depending on context.
  • NO influences glioma cell proliferation, vascularization, invasion, and treatment efficacy.
  • Diverse experimental models and NO levels/gradients contribute to observed effects.

Conclusions:

  • Targeting nitric oxide (NO) pathways offers a potential avenue for novel glioma treatments.
  • Further research is needed to clarify NO's precise roles and develop clinically applicable modulators.
  • Overcoming limitations in approved NO inhibitors and donors is essential for clinical translation.